Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
10 Jun 2025
// BIOSAPCE
https://www.biospace.com/press-releases/alnylam-receives-european-commission-approval-for-amvuttra-vutrisiran-for-the-treatment-of-attr-amyloidosis-with-cardiomyopathy
28 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250528617673/en/Alnylam-to-Webcast-Presentation-at-Goldman-Sachs-46th-Annual-Global-Healthcare-Conference
20 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250520029083/en/Alnylam-Issues-2024-Corporate-Responsibility-Report
17 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250517369489/en/AMVUTTRA-vutrisiran-Significantly-Reduces-Mortality-and-a-Range-of-Important-Cardiovascular-Events-in-Patients-with-ATTR-Amyloidosis-with-Cardiomyopathy-Additional-Data-from-HELIOS-B
14 May 2025
// REUTERS
https://www.reuters.com/legal/government/alnylam-drops-covid-vaccine-patent-case-against-pfizer-biontech-now-2025-05-14/
12 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250512731729/en/Alnylam-to-Share-Progress-Across-its-Transthyretin-Amyloidosis-Franchise-Including-Additional-Analyses-of-the-HELIOS-B-Phase-3-Study-Results-at-Heart-Failure-2025-Congress
ABOUT THIS PAGE